Function
Health
—
the
platform
that
gives
subscribers
access
to
more
than
160
different
lab
tests
—
closed
a
$298
million
Series
B
funding
round
on
Wednesday,
bringing
the
startup’s
valuation
to
$2.5
billion.
The
Austin-based
company,
which
launched
in
2023,
has
now
raised
more
than
$350
million.
After
reaching
unicorn
status,
Function
will
continue
to
focus
on
helping
people
live
longer,
healthier
lives,
according
to
CEO
Jonathan
Swerdlin.
“The
current
system
focuses
on
acute
care,
and
it’s
miraculous
for
that.
If
you
break
your
arm
or
need
surgery,
it’s
exactly
where
you
want
to
be.
However,
it’s
missing
the
key
data
points
and
integrated,
whole-body
solutions
people
need
to
stay
healthy,”
he
stated.
He
noted
that
nearly
half
of
deaths
in
the
U.S.
result
from
preventable
diseases,
yet
most
healthcare
data
lives
in
silos
and
is
generated
only
when
something
goes
wrong.
People
don’t
want
to
be
left
in
the
dark
about
their
own
wellbeing
—
they
desire
ownership
of
their
health,
Swerdlin
pointed
out.
“And
this
isn’t
just
for
biohackers
or
elite
individuals.
This
is
an
eight-billion-person
problem,”
he
declared.
Function
helps
address
this
problem
by
removing
some
of
the
barriers
around
lab
testing.
An
annual
subscription
to
Function’s
platform
costs
$365.
This
includes
access
to
lab
tests
—
which
cover
hormones,
heart
health,
immunity,
metabolism,
liver
and
kidney
function,
thyroid
and
nutrients.
Many
members
also
get
MRI
scans
through
Function,
which
start
at
$499,
as
well
as
heart
and
lungs
CT
scans,
which
start
at
$349.
Since
Function’s
launch,
members
have
now
completed
more
than
50
million
lab
tests.
Each
member
receives
an
overview
of
their
results
from
a
clinician,
a
personalized
plan
with
nutrition
and
lifestyle
recommendations,
and
outreach
from
a
clinician
if
anything
looks
concerning,
Swerdin
explained.
All
results
live
in
the
Function
app,
where
members
can
download
reports
to
share
with
their
own
clinicians.
The
platform
is
the
only
one
on
the
market
to
combine
such
a
wide
range
of
lab
testing
and
imaging
under
one
membership.
All
data
gets
integrated
into
a
single
interface,
which
gives
members
a
personalized
view
of
their
health
and
helps
them
make
more
informed
decisions,
Swerdlin
noted.
He
said
Function’s
new
influx
of
capital
will
fuel
the
advancement
of
its
AI
models,
which
are
designed
to
integrate
research
with
each
individual’s
data
for
more
proactive,
personalized
guidance.
“Over
the
next
decade,
real-world,
longitudinal
data
will
completely
reshape
expectations.
Consumers
won’t
settle
for
reactive
care
—
they’ll
expect
systems
that
continuously
learn
from
their
biology
and
alert
them
before
problems
arise,”
Swerdlin
stated.
Whether
this
model
can
deliver
on
its
promise
of
earlier
detection
and
prevention
remains
a
key
question
as
Function
enters
its
next
phase.
Photo:
Lucy
von
Held,
Getty
Images